{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:19:26Z","timestamp":1794507566367,"version":"4.9.1"},"reference-count":209,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"West China Hospital, Sichuan University, China","award":["AG000311"],"award-info":[{"award-number":["AG000311"]}]},{"name":"King Abdulaziz University, Saudi Arabia","award":["AG000311"],"award-info":[{"award-number":["AG000311"]}],"id":[{"id":"https:\/\/ror.org\/02ma4wv74","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Daffodil International University, Bangladesh","award":["AG000311"],"award-info":[{"award-number":["AG000311"]}],"id":[{"id":"https:\/\/ror.org\/052t4a858","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Intramural Research Program, National Institute on Aging, NIH, USA","award":["AG000311"],"award-info":[{"award-number":["AG000311"]}],"id":[{"id":"https:\/\/ror.org\/049v75w11","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Neuroendocrine neoplasms (NENs) are a group of heterogeneous tumors with neuroendocrine differentiation that can arise from any organ. They account for 2% of all malignancies in the United States. A significant proportion of NEN patients experience endocrine imbalances consequent to increased amine or peptide hormone secretion, impacting their quality of life and prognosis. Over the last decade, pathologic categorization, diagnostic techniques and therapeutic choices for NENs\u2014both well-differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs)\u2014have appreciably evolved. Diagnosis of NEN mostly follows a suspicion from clinical features or incidental imaging findings. Hormonal or non-hormonal biomarkers (like serum serotonin, urine 5-HIAA, gastrin and VIP) and histology of a suspected NEN is, therefore, critical for both confirmation of the diagnosis and classification as an NET or NEC. Therapy for NENs has progressed recently based on a better molecular understanding, including the involvement of mTOR, VEGF and peptide receptor radionuclide therapy (PRRT), which add to the growing evidence supporting the possibility of treatment beyond complete resection. As the incidence of NENs is on the rise in the United States and several other countries, physicians are more likely to see these cases, and their better understanding may support earlier diagnosis and tailoring treatment to the patient. We have compiled clinically significant evidence for NENs, including relevant changes to clinical practice that have greatly updated our diagnostic and therapeutic approach for NEN patients.<\/jats:p>","DOI":"10.3390\/jcm12155138","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T10:25:36Z","timestamp":1691231136000},"page":"5138","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["A Comprehensive Review on Neuroendocrine Neoplasms: Presentation, Pathophysiology and Management"],"prefix":"10.3390","volume":"12","author":[{"given":"Qamar","family":"Sultana","sequence":"first","affiliation":[{"name":"Department of Medicine, Deccan College of Medical Sciences, Hyderabad 500058, India"},{"name":"PearResearch, Dehradun 248001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Kar","sequence":"additional","affiliation":[{"name":"PearResearch, Dehradun 248001, India"},{"name":"Department of Medicine, Lady Hardinge Medical College, New Delhi 110001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2499-4874","authenticated-orcid":false,"given":"Amogh","family":"Verma","sequence":"additional","affiliation":[{"name":"PearResearch, Dehradun 248001, India"},{"name":"Rama Medical College Hospital and Research Centre, Hapur 245304, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Sanghvi","sequence":"additional","affiliation":[{"name":"PearResearch, Dehradun 248001, India"},{"name":"Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai 400022, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4379-9265","authenticated-orcid":false,"given":"Nirja","family":"Kaka","sequence":"additional","affiliation":[{"name":"PearResearch, Dehradun 248001, India"},{"name":"Department of Medicine, GMERS Medical College, Himmatnagar 390021, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4702-8583","authenticated-orcid":false,"given":"Neil","family":"Patel","sequence":"additional","affiliation":[{"name":"PearResearch, Dehradun 248001, India"},{"name":"Department of Medicine, GMERS Medical College, Himmatnagar 390021, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0345-3876","authenticated-orcid":false,"given":"Yashendra","family":"Sethi","sequence":"additional","affiliation":[{"name":"PearResearch, Dehradun 248001, India"},{"name":"Government Doon Medical College, HNB Uttarakhand Medical Education University, Dehradun 248001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8867-7603","authenticated-orcid":false,"given":"Hitesh","family":"Chopra","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0088-0565","authenticated-orcid":false,"given":"Mohammad Amjad","family":"Kamal","sequence":"additional","affiliation":[{"name":"Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610017, China"},{"name":"King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia"},{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1216, Bangladesh"},{"name":"Enzymoics, Hebersham, NSW 2770, Australia"},{"name":"Novel Global Community Educational Foundation, Hebersham, NSW 2770, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3032-1468","authenticated-orcid":false,"given":"Nigel H.","family":"Greig","sequence":"additional","affiliation":[{"name":"Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3322\/caac.21493","article-title":"Gastroenteropancreatic Neuroendocrine Tumors","volume":"68","author":"Cives","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1530\/ERC-19-0437","article-title":"Fishing for Neuroendocrine Tumors","volume":"27","author":"Gaudenzi","year":"2020","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the Incidence, Prevalence, and Survival Outcomes in Patients with Neuroendocrine Tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","article-title":"Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas","volume":"19","author":"Oronsky","year":"2017","journal-title":"Neoplasia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One Hundred Years after \u201cCarcinoid\u201d: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/ijc.30400","article-title":"The Epidemiology of Metastases in Neuroendocrine Tumors","volume":"139","author":"Hemminki","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.14694\/EdBook_AM.2015.35.92","article-title":"The Spectrum of Neuroendocrine Tumors: Histologic Classification, Unique Features and Areas of Overlap","volume":"35","author":"Klimstra","year":"2015","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/COC.0b013e31807a2f49","article-title":"Neuroendocrine Tumors of the Gastrointestinal Tract: A Decade of Experience at the Princess Margaret Hospital","volume":"31","author":"Rothenstein","year":"2008","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1590\/1806-9282.63.10.856","article-title":"Neuroendocrine Tumors: An Epidemiological Study of 250 Cases at a Tertiary Hospital","volume":"63","author":"Silveira","year":"2017","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00000658-198802000-00015","article-title":"Neuroendocrine (Merkel Cell) Carcinoma of the Skin. Its Natural History, Diagnosis, and Treatment","volume":"207","author":"Hitchcock","year":"1988","journal-title":"Ann. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1309\/7NK9-VUAL-9WU2-KJ19","article-title":"Neuroendocrine Tumors of the Thyroid Gland","volume":"115","author":"Baloch","year":"2001","journal-title":"Pathol. Patterns Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3941\/jrcr.v14i1.3737","article-title":"Primary Neuroendocrine Tumor of the Thymus: Radiological and Pathological Correlation","volume":"14","author":"Berman","year":"2020","journal-title":"J. Radiol. Case Rep."},{"key":"ref_14","first-page":"527","article-title":"Classification of Neuroendocrine Neoplasms: Lights and Shadows","volume":"22","author":"Uccella","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.hoc.2015.08.006","article-title":"Clinical Presentation and Diagnosis of Neuroendocrine Tumors","volume":"30","author":"Vinik","year":"2016","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2174\/1871520617666170213113401","article-title":"Therapeutic Challenges in Neuroendocrine Tumors","volume":"17","author":"Legakis","year":"2017","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2217\/fon-2017-0667","article-title":"IFN-\u03b1 in Advanced Well-Differentiated Neuroendocrine Tumors: The Neglected Drug?","volume":"14","author":"Amoroso","year":"2018","journal-title":"Future Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.21037\/jgo.2016.12.09","article-title":"Biologics in Gastrointestinal and Pancreatic Neuroendocrine Tumors","volume":"8","author":"Liu","year":"2017","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chow, Z., Johnson, J., Johnson, J.J., Chauhan, A., Izumi, T., Cavnar, M.J., Weiss, H.L., Townsend, C.M., Anthony, L., and Wasilchenko, C. (2021). PI3K\/MTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors. Cells, 10.","DOI":"10.3390\/cells10051261"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.2147\/OTT.S115054","article-title":"Prognostic Value of PD-L1 and PD-1 Expression in Pulmonary Neuroendocrine Tumors","volume":"9","author":"Fan","year":"2016","journal-title":"OncoTargets Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcmgh.2014.12.008","article-title":"Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology","volume":"1","author":"Kidd","year":"2015","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.anndiagpath.2017.04.005","article-title":"Recent Updates on Grading and Classification of Neuroendocrine Tumors","volume":"29","author":"Kim","year":"2017","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_23","unstructured":"Cancer.Net (2023, June 10). Neuroendocrine Tumors: Grades. Available online: https:\/\/www.cancer.net\/cancer-types\/neuroendocrine-tumors\/grades."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","article-title":"The Pathologic Classification of Neuroendocrine Tumors: A Review of Nomenclature, Grading, and Staging Systems","volume":"39","author":"Klimstra","year":"2010","journal-title":"Pancreas"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000085237","article-title":"Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours. A Consensus Statement on Behalf of the European Neuroendocrine Tumour Society (ENETS)","volume":"80","author":"Rindi","year":"2004","journal-title":"Neuroendocrinology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: The 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.athoracsur.2019.09.053","article-title":"Staging System for Neuroendocrine Tumors of the Lung Needs to Incorporate Histologic Grade","volume":"109","author":"Jackson","year":"2020","journal-title":"Ann. Thorac. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1634\/theoncologist.2008-0207","article-title":"Carcinoid Tumors","volume":"13","author":"Pinchot","year":"2008","journal-title":"Oncologist"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00001610-200205000-00004","article-title":"Carcinoid Tumors and Syndrome","volume":"25","author":"McCormick","year":"2002","journal-title":"Gastroenterol. Nurs."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Tempfer, C.B., Tischoff, I., Dogan, A., Hilal, Z., Schultheis, B., Schultheis, B., Kern, P., and Rezniczek, G.A. (2018). Neuroendocrine Carcinoma of the Cervix: A Systematic Review of the Literature. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4447-x"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/030089161009600114","article-title":"Surgical Management of Bronchopulmonary Carcinoid Tumors: Experience over 8 Years and Review of the Literature","volume":"96","author":"Kudlac","year":"2010","journal-title":"Tumori J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.path.2019.08.012","article-title":"Neuroendocrine Tumors of the Lung: Updates and Diagnostic Pitfalls","volume":"12","author":"Hung","year":"2019","journal-title":"Surg. Pathol. Clin."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ctrv.2012.06.012","article-title":"Treatment of Pulmonary Neuroendocrine Tumours: State of the Art and Future Developments","volume":"39","author":"Gridelli","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0003-4975(02)04118-8","article-title":"Large Cell Neuroendocrine Carcinoma and Large Cell Carcinomas with Neuroendocrine Morphology of the Lung: Prognosis after Complete Resection and Systematic Nodal Dissection","volume":"75","author":"Zacharias","year":"2003","journal-title":"Ann. Thorac. Surg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cncr.23542","article-title":"Bronchopulmonary Neuroendocrine Tumors","volume":"113","author":"Gustafsson","year":"2008","journal-title":"Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.athoracsur.2009.07.097","article-title":"Management of Carcinoid Tumors","volume":"89","author":"Detterbeck","year":"2010","journal-title":"Ann. Thorac. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/0284186X.2015.1067715","article-title":"Diagnosis and Treatment of Bronchopulmonary Neuroendocrine Tumours: State of the Art","volume":"55","author":"Tabaksblat","year":"2016","journal-title":"Acta Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5858\/arpa.2015-0314-RA","article-title":"Recent Updates on Neuroendocrine Tumors from the Gastrointestinal and Pancreatobiliary Tracts","volume":"140","author":"Kim","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archsurg.143.5.471","article-title":"Rectal Carcinoid Tumors: Review of Results after Endoscopic and Surgical Therapy","volume":"143","author":"Kwaan","year":"2008","journal-title":"Arch. Surg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00423-001-0260-z","article-title":"Neuroendocrine Tumours of the Duodenum","volume":"386","author":"Witzigmann","year":"2002","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bpg.2005.05.009","article-title":"Duodenal Neuroendocrine Tumors: Classification, Functional Syndromes, Diagnosis and Medical Treatment","volume":"19","author":"Hoffmann","year":"2005","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_42","first-page":"70","article-title":"Gastrointestinal Neuroendocrine Tumors: Pathogenesis and Imaging","volume":"16","author":"Rydzewska","year":"2013","journal-title":"Nucl. Med. Rev. Cent. East. Eur."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"bcr-2018","DOI":"10.1136\/bcr-2018-226702","article-title":"Duodenal Somatostatinoma Presenting as Obstructive Jaundice with the Coexistence of a Gastrointestinal Stromal Tumour in Neurofibromatosis Type 1: A Case with Review of the Literature","volume":"12","author":"Thavaraputta","year":"2019","journal-title":"BMJ Case Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11912-017-0567-8","article-title":"Radionuclide Therapy for Neuroendocrine Tumors","volume":"19","author":"Cives","year":"2017","journal-title":"Curr. Oncol. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1245\/s10434-018-6673-5","article-title":"Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-Center Experience","volume":"25","author":"Massironi","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.suc.2020.02.010","article-title":"Neuroendocrine Tumors of the Pancreatobiliary and Gastrointestinal Tracts","volume":"100","author":"Bonds","year":"2020","journal-title":"Surg. Clin. N. Am."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bpg.2005.06.003","article-title":"Neuroendocrine Tumours (Carcinoids) of the Appendix","volume":"19","author":"Stinner","year":"2005","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_48","first-page":"429","article-title":"Carcinoid Tumors","volume":"74","author":"Robertson","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/modpathol.3880423","article-title":"Clinicopathologic and DNA Cytometric Analysis of Carcinoid Tumors of the Thymus","volume":"14","author":"Goto","year":"2001","journal-title":"Mod. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.mog.0000239868.27328.1d","article-title":"Rectal Carcinoids","volume":"22","author":"Wang","year":"2006","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijsu.2014.03.002","article-title":"Diagnosis and Treatment Experience of Rectal Carcinoid (a Report of 312 Cases)","volume":"12","author":"Yangong","year":"2014","journal-title":"Int. J. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/MOG.0b013e328011752a","article-title":"Large Bowel Carcinoid Tumors","volume":"23","author":"Northrop","year":"2007","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1007\/s00464-014-3430-0","article-title":"Rectal Carcinoids: A Systematic Review","volume":"28","author":"McDermott","year":"2014","journal-title":"Surg. Endosc. Other Interv. Tech."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(22)00750-1","article-title":"Hemicolectomy versus Appendectomy for Patients with Appendiceal Neuroendocrine Tumours 1\u20132 Cm in Size: A Retrospective, Europe-Wide, Pooled Cohort Study","volume":"24","author":"Nesti","year":"2023","journal-title":"Lancet Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jss.2013.05.107","article-title":"Clinicopathologic Characteristics of Colonic Carcinoid Tumors","volume":"184","author":"Murray","year":"2013","journal-title":"J. Surg. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.anndiagpath.2019.06.009","article-title":"Neuroendocrine Tumors of Genitourinary Tract: Recent Advances","volume":"42","author":"Shehabeldin","year":"2019","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/PAP.0b013e3180ca8a89","article-title":"Neuroendocrine Lesions of the Genitourinary Tract","volume":"14","author":"Fine","year":"2007","journal-title":"Adv. Anat. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.clgc.2014.06.008","article-title":"Neuroendocrine Tumors of the Kidney: A Single Institution Experience","volume":"12","author":"Teegavarapu","year":"2014","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11912-017-0617-2","article-title":"Pathology of Neuroendocrine Tumours of the Female Genital Tract","volume":"19","author":"Howitt","year":"2017","journal-title":"Curr. Oncol. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1053\/adpa.2002.36661","article-title":"Small Cell Carcinoma of the Cervix: A Clinicopathologic and Immunohistochemical Study of 23 Cases","volume":"6","author":"Conner","year":"2002","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1007\/s00261-016-1012-4","article-title":"Neuroendocrine Neoplasms of the Genitourinary Tract in Adults: Cross-Sectional Imaging Spectrum","volume":"42","author":"Katabathina","year":"2017","journal-title":"Abdom. Radiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1007\/s00595-020-01988-7","article-title":"Neuroendocrine Tumors of the Lung: Clinicopathological and Molecular Features","volume":"50","author":"Iyoda","year":"2020","journal-title":"Surg. Today"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/21548331.2016.1210474","article-title":"Pancreatic Neuroendocrine Tumors: Contemporary Diagnosis and Management","volume":"44","author":"Parbhu","year":"2016","journal-title":"Hosp. Pract."},{"key":"ref_64","unstructured":"Townsend, C.M. (2022). Sabiston Textbook of Surgery, Elsevier."},{"key":"ref_65","unstructured":"Prosapio, J.G., Jialal, I., and Sankar, P. (2022). Physiology, Gastrin, StatPearls Publishing."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/CAD.0000000000000633","article-title":"An Update on the Management of Pancreatic Neuroendocrine Tumors","volume":"29","author":"Gao","year":"2018","journal-title":"Anticancer Drugs"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAP.0000000000000201","article-title":"Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances","volume":"26","author":"Guilmette","year":"2019","journal-title":"Adv. Anat. Pathol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","article-title":"The High-Grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms","volume":"39","author":"Basturk","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic Neuroendocrine Neoplasms: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_70","first-page":"346","article-title":"The Diagnosis and Treatment of Pancreatic NEN-G3-A Focus on Clinicopathological Difference of NET-G3 and NEC G3","volume":"3","author":"Hijioka","year":"2018","journal-title":"J. Pancreas"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/arpa.2019-0338-RA","article-title":"A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms with a Focus on the New World Health Organization Classification","volume":"143","author":"Fang","year":"2019","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/EJE-19-0332","article-title":"Anatomic Site as Prognostic Marker of Pancreatic Neuroendocrine Tumors: A Cohort Study","volume":"181","author":"Badarna","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S1470-2045(21)00572-6","article-title":"177Lu-Dotatate plus Long-Acting Octreotide versus High-dose Long-Acting Octreotide in Patients with Midgut Neuroendocrine Tumours (NETTER-1): Final Overall Survival and Long-Term Safety Results from an Open-Label, Randomised, Controlled, Phase 3 Trial","volume":"22","author":"Strosberg","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.surg.2019.04.061","article-title":"Operative Resection in Early Stage Pancreatic Neuroendocrine Tumors in the United States: Are We over- or Undertreating Patients?","volume":"167","author":"Chivukula","year":"2020","journal-title":"Surgery"},{"key":"ref_75","unstructured":"Zhuo, F., and Anastasopoulou, C. (2022). Insulinoma, StatPearls Publishing."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Rahman, S., Hossain, K.S., Das, S., Kundu, S., Adegoke, E.O., Adegoke, E.O., Rahman, M.A., Rahman, M.A., Rahman, M.A., and Rahman, A. (2021). Role of Insulin in Health and Disease: An Update. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126403"},{"key":"ref_77","unstructured":"Mathew, P., and Thoppil, D. (2022). Hypoglycemia, StatPearls Publishing."},{"key":"ref_78","first-page":"e249698","article-title":"Pancreatic Neuroendocrine Tumour\u2014Insulinoma Masquerading as a Psychiatric Illness","volume":"15","author":"Karanth","year":"2022","journal-title":"Case Rep."},{"key":"ref_79","first-page":"1302","article-title":"Insulinomas: From Diagnosis to Treatment. A Review of the Literature","volume":"25","author":"Giannis","year":"2020","journal-title":"J. Buon"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s10620-020-06379-z","article-title":"Using the Secretion Ratios of Insulin and C-Peptide During the 2-h Oral Glucose Tolerance Test to Diagnose Insulinoma","volume":"66","author":"Liao","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1210\/jcem.85.9.6807","article-title":"Forty-Eight-Hour Fast: The Diagnostic Test for Insulinoma","volume":"85","author":"Hirshberg","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e25076","DOI":"10.1097\/MD.0000000000025076","article-title":"Ectopic Insulinoma Diagnosed by 68Ga-Exendin-4 PET\/CT","volume":"100","author":"Zhang","year":"2021","journal-title":"Medicine"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e936723","DOI":"10.12659\/AJCR.936723","article-title":"Diagnosis and Treatment Course of Insulinoma Presenting as Hypoglycemia Unawareness Using a Factory-Calibrated Continuous Glucose Monitoring System","volume":"23","author":"Aida","year":"2022","journal-title":"Am. J. Case Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/jdv.13752","article-title":"Glucagonoma Syndrome: A Review and Update on Treatment","volume":"30","author":"John","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_85","unstructured":"Rix, I., Nex\u00f8e-Larsen, C., Bergmann, N.C., Lund, A., and Knop, F.K. (2000). Glucagon Physiology, MDText.com, Inc."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/DAD.0000000000001219","article-title":"Glucagonoma-Associated Necrolytic Migratory Erythema: The Broad Spectrum of the Clinical and Histopathological Findings and Clues to the Diagnosis","volume":"41","author":"Toberer","year":"2019","journal-title":"Am. J. Dermatopathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1111\/ajd.13323","article-title":"Pseudoglucagonoma Syndrome: Description of an \u2018Idiopatic\u2019 Case","volume":"61","author":"Ferrara","year":"2020","journal-title":"Australas. J. Dermatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jlcr.3750","article-title":"Exendin-4 Analogs in Insulinoma Theranostics","volume":"62","author":"Jansen","year":"2019","journal-title":"J. Label. Comp. Radiopharm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.hbpd.2021.09.005","article-title":"Glucagonoma Syndrome with Necrolytic Migratory Erythema as Initial Manifestation","volume":"20","author":"Zhu","year":"2021","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e17037","DOI":"10.1097\/MD.0000000000017037","article-title":"Spleen-Preserving Distal Pancreatectomy and Lymphadenectomy for Glucagonoma Syndrome","volume":"98","author":"Cao","year":"2019","journal-title":"Medicine"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11864-001-0027-3","article-title":"Gastrinoma","volume":"2","author":"Li","year":"2001","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.soc.2006.05.001","article-title":"Gastrinoma: Sporadic and Familial Disease","volume":"15","author":"Libutti","year":"2006","journal-title":"Surg. Oncol. Clin."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s12055-021-01211-3","article-title":"Primary Thoracic Gastrinoma Causing Zollinger-Ellison Syndrome","volume":"37","author":"Rafieian","year":"2021","journal-title":"Indian. J. Thorac. Cardiovasc. Surg."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.3748\/wjg.v27.i35.5890","article-title":"Gastrinoma and Zollinger Ellison Syndrome: A Roadmap for the Management between New and Old Therapies","volume":"27","author":"Rossi","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/14656566.2013.767332","article-title":"Pharmacotherapy of Zollinger\u2013Ellison Syndrome","volume":"14","author":"Ito","year":"2013","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1210\/jcem.85.11.6963","article-title":"Expression of the Calcium-Sensing Receptor in Gastrinomas","volume":"85","author":"Goebel","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_97","unstructured":"DiGregorio, N., and Sharma, S. (2022). Physiology, Secretin, StatPearls Publishing."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12020-017-1420-4","article-title":"The Zollinger-Ellison Syndrome: Is There a Role for Somatostatin Analogues in the Treatment of the Gastrinoma?","volume":"60","author":"Guarnotta","year":"2018","journal-title":"Endocrine"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ecl.2018.04.009","article-title":"Gastrinomas","volume":"47","author":"Norton","year":"2018","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_100","first-page":"3383","article-title":"Somatostatinoma: Beyond Neurofibromatosis Type 1 (Review)","volume":"20","author":"Sandru","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Martin, S., Fica, S., Parfeni, O., Popa, L., Manuc, T., Rizea, O., Lupescu, I., Gherghe, M., Becheanu, G., and Croitoru, A. (2020). Somatostatinoma and Neurofibromatosis Type 1-A Case Report and Review of the Literature. Diagnostics, 10.","DOI":"10.3390\/diagnostics10090620"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpg.2012.12.003","article-title":"Pancreatic Neuroendocrine Tumors: Clinical Features, Diagnosis and Medical Treatment: Advances","volume":"26","author":"Ito","year":"2012","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_103","unstructured":"Zandee, W.T., Hofland, J., and de Herder, W.W. (2000). Vasoactive Intestinal Peptide Tumor (VIPoma), MDText.com, Inc."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(87)90425-6","article-title":"Vipoma Syndrome","volume":"82","author":"Krejs","year":"1987","journal-title":"Am. J. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12664-012-0257-2","article-title":"Pancreatic Neuroendocrine Tumors","volume":"32","author":"Shrikhande","year":"2013","journal-title":"Indian J. Gastroenterol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/MPA.0000000000001402","article-title":"Vasoactive Intestinal Peptide\u2013Secreting Tumors","volume":"48","author":"Siddappa","year":"2019","journal-title":"Pancreas"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.pan.2021.08.001","article-title":"Efficacy of Treatments for VIPoma: A GTE Multicentric Series","volume":"21","author":"Brugel","year":"2021","journal-title":"Pancreatology"},{"key":"ref_108","first-page":"2548","article-title":"Basics for Surgeons about the Immunohistochemistry Role in Pancreatic NETs Diagnosis","volume":"25","author":"Romano","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2217\/fon.14.285","article-title":"Pancreatic Neuroendocrine Tumors: A Review","volume":"11","author":"Young","year":"2015","journal-title":"Future Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"82784","DOI":"10.18632\/oncotarget.20007","article-title":"Functional and Non-Functional Pancreatic Neuroendocrine Tumours: ENETS or AJCC TNM Staging System?","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/PAP.0000000000000019","article-title":"Adrenocortical Carcinoma","volume":"21","author":"Erickson","year":"2014","journal-title":"Adv. Anat. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s13691-019-00368-4","article-title":"Primary Small Cell Neuroendocrine Carcinoma of Adrenal Gland","volume":"8","author":"Ogawa","year":"2019","journal-title":"Int. Cancer Conf. J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1148\/rg.266065057","article-title":"Integrated PET-CT for the Characterization of Adrenal Gland Lesions in Cancer Patients: Diagnostic Efficacy and Interpretation Pitfalls","volume":"26","author":"Chong","year":"2006","journal-title":"RadioGraphics"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bju.13592","article-title":"International Consultation on Urological Diseases and European Association of Urology International Consultation on Minimally Invasive Surgery in Urology: Laparoscopic and Robotic Adrenalectomy","volume":"119","author":"Ball","year":"2017","journal-title":"BJU Int."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"102992","DOI":"10.1016\/j.amjoto.2021.102992","article-title":"Neuroendocrine Carcinomas of the Head and Neck: A Small Case Series","volume":"42","author":"Mitchell","year":"2021","journal-title":"Am. J. Otolaryngol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.thorsurg.2010.08.013","article-title":"Neuroendocrine Tumors of the Thymus","volume":"21","author":"Ruffini","year":"2011","journal-title":"Thorac. Surg. Clin."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s40618-020-01456-6","article-title":"Correlation of Molecular Data with Histopathological and Clinical Features in a Series of 66 Patients with Medullary Thyroid Carcinoma","volume":"44","author":"Moura","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"610230","DOI":"10.3389\/fendo.2020.610230","article-title":"Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues","volume":"11","author":"Gallo","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1259\/0007-1285-69-819-226","article-title":"Merkel Cell Carcinoma of the Skin: Imaging and Clinical Features in 93 Cases","volume":"69","author":"Eftekhari","year":"1996","journal-title":"Br. J. Radiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/er.2018-00160","article-title":"Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms","volume":"40","author":"Mafficini","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11864-020-00749-5","article-title":"Hereditary Syndromes in Neuroendocrine Tumors","volume":"21","author":"Lewis","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","article-title":"Clinical Aspects of Multiple Endocrine Neoplasia Type 1","volume":"17","author":"Cadiot","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/GIM.0b013e318216cc6d","article-title":"Multiple Endocrine Neoplasia Type 2: An Overview","volume":"13","author":"Moline","year":"2011","journal-title":"Genet. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.3748\/wjg.v24.i33.3806","article-title":"Neurofibromatosis Type 1-Associated Multiple Rectal Neuroendocrine Tumors: A Case Report and Review of the Literature","volume":"24","author":"Xie","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cncr.23648","article-title":"Inherited Pancreatic Endocrine Tumor Syndromes: Advances in Molecular Pathogenesis, Diagnosis, Management, and Controversies","volume":"113","author":"Jensen","year":"2008","journal-title":"Cancer"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.hoc.2015.09.006","article-title":"Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment","volume":"30","author":"Fishbein","year":"2016","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3322\/caac.20097","article-title":"Recent Progress in the Understanding, Diagnosis, and Treatment of Gastroenteropancreatic Neuroendocrine Tumors","volume":"61","author":"Turaga","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7861\/clinmedicine.12-4-377","article-title":"Nuclear Medicine Imaging of Neuroendocrine Tumours","volume":"12","year":"2012","journal-title":"Clin. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00261-016-0904-7","article-title":"Cross Sectional and Nuclear Medicine Imaging of Pancreatic Insulinomas","volume":"42","author":"Rayamajhi","year":"2017","journal-title":"Abdom. Radiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1210\/jc.2019-01204","article-title":"Surgical Management, Preoperative Tumor Localization, and Histopathology of 80 Patients Operated on for Insulinoma","volume":"104","author":"Andreassen","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000471879","article-title":"ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging","volume":"105","author":"Sundin","year":"2017","journal-title":"Neuroendocrinology"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000443170","article-title":"ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum","volume":"103","author":"Niederle","year":"2016","journal-title":"Neuroendocrinology"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT","volume":"48","author":"Gabriel","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MED.0000000000000300","article-title":"Molecular Imaging in Neuroendocrine Tumors","volume":"24","author":"Ito","year":"2016","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/endrev\/bnz004","article-title":"Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms","volume":"41","author":"Hofland","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.3748\/wjg.v19.i23.3678","article-title":"Diagnostic Accuracy of Endoscopic Ultrasound in Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta Analysis","volume":"19","author":"Puli","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000457956","article-title":"ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology\u2014Diagnosis and Prognostic Stratification","volume":"105","author":"Perren","year":"2017","journal-title":"Neuroendocrinology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11886-019-1207-8","article-title":"Carcinoid Heart Disease: A Comprehensive Review","volume":"21","author":"Hassan","year":"2019","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/frne.2001.0218","article-title":"Neuroendocrine Tumor Markers","volume":"22","author":"Lamberts","year":"2001","journal-title":"Front. Neuroendocr."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000051853","article-title":"Tumor Markers in Neuroendocrine Tumors","volume":"62","author":"Eriksson","year":"2000","journal-title":"Digestion"},{"key":"ref_141","first-page":"2622","article-title":"Chromogranin A as Serum Marker for Neuroendocrine Neoplasia: Comparison with Neuron-Specific Enolase and the \u03b1-Subunit of Glycoprotein Hormones","volume":"82","author":"Nobels","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0167-0115(95)00069-N","article-title":"Chromogranin A: Current Status as a Precursor for Bioactive Peptides and a Granulogenic\/Sorting Factor in the Regulated Secretory Pathway","volume":"58","author":"Iacangelo","year":"1995","journal-title":"Regul. Pept."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMra021405","article-title":"The Chromogranin\u2013Secretogranin Family","volume":"348","author":"Taupenot","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/annonc\/12.suppl_2.S79","article-title":"Impact of Chromogranin A Measurement in the Work-up of Neuroendocrine Tumors","volume":"12","author":"Baudin","year":"2001","journal-title":"Ann. Oncol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00005792-199101000-00003","article-title":"Chromogranin A Storage and Secretion: Sensitivity and Specificity for the Diagnosis of Pheochromocytoma","volume":"70","author":"Hsiao","year":"1991","journal-title":"Medicine"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/bjc.1998.635","article-title":"Neuron-Specific Enolase and Chromogranin A as Markers of Neuroendocrine Tumours","volume":"78","author":"Baudin","year":"1998","journal-title":"Br. J. Cancer"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/A:1008215730767","article-title":"Carcinoid Tumors: Analysis of Prognostic Factors and Survival in 301 Patients from a Referral Center","volume":"8","author":"Janson","year":"1997","journal-title":"Ann. Oncol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0959-8049(01)00073-9","article-title":"Antitumour Activity of Somatostatin Analogues in Progressive Metastatic Neuroendocrine Tumours","volume":"37","author":"Aparicio","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1507\/endocrj.44.319","article-title":"Plasma Chromogranin A in Pheochromocytoma, Primary Hyperparathyroidism and Pituitary Adenoma in Comparison with Catecholamine, Parathyroid Hormone and Pituitary Hormones","volume":"44","author":"Kimura","year":"1997","journal-title":"Endocr. J."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJM198605013141803","article-title":"Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms","volume":"314","author":"Deftos","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bjc.6690745","article-title":"Chromogranin A, a Significant Prognostic Factor in Small Cell Lung Cancer","volume":"81","author":"Drivsholm","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00001622-200201000-00008","article-title":"Carcinoid Tumors: Molecular Genetics, Tumor Biology, and Update of Diagnosis and Treatment","volume":"14","year":"2002","journal-title":"Curr. Opin. Oncol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1677\/joe.0.1770337","article-title":"A Comparison between Three Commercial Kits for Chromogranin A Measurements","volume":"177","author":"Stridsberg","year":"2003","journal-title":"J. Endocrinol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1148\/radiology.212.1.r99jl3035","article-title":"Pheochromocytomas: Imaging with 2-[Fluorine-18]Fluoro-2-Deoxy-d-Glucose PET","volume":"212","author":"Shulkin","year":"1999","journal-title":"Radiology"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/er.2003-0014","article-title":"The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors","volume":"25","author":"Kaltsas","year":"2004","journal-title":"Endocr. Rev."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1677\/ERC-09-0078","article-title":"Somatostatin Receptor-Based Imaging and Therapy of Gastroenteropancreatic Neuroendocrine Tumors","volume":"17","author":"Kwekkeboom","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000473892","article-title":"ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy\u2014Chemotherapy","volume":"105","author":"Rinke","year":"2017","journal-title":"Neuroendocrinology"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0972-3919.125760","article-title":"PET\/CT Imaging of Neuroendocrine Tumors with 68 Gallium-Labeled Somatostatin Analogues: An Overview and Single Institutional Experience from India","volume":"29","author":"Kumar","year":"2014","journal-title":"Indian J. Nucl. Med."},{"key":"ref_159","first-page":"71","article-title":"Changing Paradigms with Molecular Imaging of Neuroendocrine Tumors","volume":"14","author":"Hofman","year":"2012","journal-title":"Discov. Med."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Alevroudis, E., Spei, M.-E., Chatziioannou, S.N., Tsoli, M., Wallin, G., Kaltsas, G., and Daskalakis, K. (2021). Clinical Utility of 18F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis. Cancers, 13.","DOI":"10.3390\/cancers13081813"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000471880","article-title":"ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy\u2014Biotherapy and Novel Targeted Agents","volume":"105","author":"Pavel","year":"2017","journal-title":"Neuroendocrinology"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000201206","article-title":"Clinical Management of Gastric Carcinoid Tumors","volume":"55","author":"Ahlman","year":"1994","journal-title":"Digestion"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.surg.2005.09.016","article-title":"Carcinoid Tumors of the Duodenum","volume":"138","author":"Mullen","year":"2005","journal-title":"Surgery"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000335595","article-title":"ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms","volume":"95","author":"Kwekkeboom","year":"2012","journal-title":"Neuroendocrinology"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/EJE-08-0420","article-title":"Long-Acting Somatostatin Analogues Are an Effective Treatment for Type 1 Gastric Carcinoid Tumours","volume":"159","author":"Kaltsas","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1677\/erc.0.0100469","article-title":"Surgery for Midgut Carcinoid","volume":"10","author":"Sutton","year":"2003","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00268-013-1918-8","article-title":"Resection of At-Risk Mesenteric Lymph Nodes Is Associated with Improved Survival in Patients with Small Bowel Neuroendocrine Tumors","volume":"37","author":"Landry","year":"2013","journal-title":"World J. Surg."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1634\/theoncologist.2015-0470","article-title":"The Role of Capecitabine\/Temozolomide in Metastatic Neuroendocrine Tumors","volume":"21","author":"Ramirez","year":"2016","journal-title":"Oncologist"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2217\/fon-2016-0434","article-title":"Capecitabine and Temozolomide in Grade 1\/2 Neuroendocrine Tumors: A Spanish Multicenter Experience","volume":"13","author":"Crespo","year":"2017","journal-title":"Future Oncol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/ERC-11-0367","article-title":"Pasireotide (SOM230) Shows Efficacy and Tolerability in the Treatment of Patients with Advanced Neuroendocrine Tumors Refractory or Resistant to Octreotide LAR: Results from a Phase II Study","volume":"19","author":"Kvols","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.hoc.2015.09.003","article-title":"Bronchial and Thymic Carcinoid Tumors","volume":"30","author":"Litvak","year":"2016","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1634\/theoncologist.2014-0120","article-title":"Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients with Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study","volume":"19","author":"Strosberg","year":"2014","journal-title":"Oncologist"},{"key":"ref_174","first-page":"223","article-title":"Factors Predicting Tracer Uptake in Somatostatin Receptor and MIBG Scintigraphy of Metastatic Gastroenteropancreatic Neuroendocrine Tumors","volume":"47","author":"Ezziddin","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000335629","article-title":"ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas","volume":"95","author":"Pape","year":"2012","journal-title":"Neuroendocrinology"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1634\/theoncologist.2012-0263","article-title":"Everolimus Plus Octreotide Long-Acting Repeatable in Patients with Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study","volume":"18","author":"Castellano","year":"2013","journal-title":"Oncologist"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.surg.2012.08.038","article-title":"Small, Nonfunctioning, Asymptomatic Pancreatic Neuroendocrine Tumors (PNETs): Role for Nonoperative Management","volume":"152","author":"Lee","year":"2012","journal-title":"Surgery"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archsurg.2011.1843","article-title":"Surgical Management of Insulinomas","volume":"147","author":"Crippa","year":"2012","journal-title":"Arch. Surg."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.beem.2015.10.003","article-title":"Surgical Management of Neuroendocrine Tumors","volume":"30","author":"Tamburrino","year":"2016","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000189549.51913.d8","article-title":"Outcome of Duodenopancreatic Resections in Patients with Multiple Endocrine Neoplasia Type 1","volume":"242","author":"Bartsch","year":"2005","journal-title":"Ann. Surg."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/SLA.0b013e3182536339","article-title":"Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated with Multiple Endocrine Neoplasia Type 1","volume":"257","author":"Lopez","year":"2013","journal-title":"Ann. Surg."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I","article-title":"Treatment of Neuroendocrine Carcinomas with Combined Etoposide and Cisplatin. Evidence of Major Therapeutic Activity in the Anaplastic Variants of These Neoplasms","volume":"68","author":"Moertel","year":"1991","journal-title":"Cancer"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1200\/JCO.2004.04.024","article-title":"Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients with Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas","volume":"22","author":"Kouvaraki","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/cncr.25425","article-title":"First-Line Chemotherapy with Capecitabine and Temozolomide in Patients with Metastatic Pancreatic Endocrine Carcinomas","volume":"117","author":"Strosberg","year":"2011","journal-title":"Cancer"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/cncr.28760","article-title":"Therapeutic Strategies for Neuroendocrine Liver Metastases","volume":"121","author":"Frilling","year":"2015","journal-title":"Cancer"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/bjs.6468","article-title":"Treatment of Liver Metastases from Neuroendocrine Tumours in Relation to the Extent of Hepatic Disease","volume":"96","author":"Frilling","year":"2009","journal-title":"Br. J. Surg."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/SLA.0b013e31816a7061","article-title":"Two-Step Surgery for Synchronous Bilobar Liver Metastases from Digestive Endocrine Tumors: A Safe Approach for Radical Resection","volume":"247","author":"Kianmanesh","year":"2008","journal-title":"Ann. Surg."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","article-title":"Right Portal Vein Ligation Combined with In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings","volume":"255","author":"Schnitzbauer","year":"2012","journal-title":"Ann. Surg."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1245\/s10434-014-3523-y","article-title":"Liver Transplantation for Unresectable Neuroendocrine Tumor Liver Metastases","volume":"21","author":"Rossi","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/SLA.0b013e3181bdf8cf","article-title":"Hepatic Metastases from Neuroendocrine Tumors with a \u201cThin Slice\u201d Pathological Examination","volume":"251","author":"Elias","year":"2010","journal-title":"Ann. Surg."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Gurusamy, K.S., Ramamoorthy, R., Sharma, D., and Davidson, B.R. (2009). Liver Resection versus Other Treatments for Neuroendocrine Tumours in Patients with Resectable Liver Metastases. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD007060.pub2"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1200\/JCO.2016.68.0702","article-title":"Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers from the Randomized, Phase III RADIANT-3 Study","volume":"34","author":"Yao","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S1470-2045(17)30681-2","article-title":"Efficacy and Safety of Long-Acting Pasireotide or Everolimus Alone or in Combination in Patients with Advanced Carcinoids of the Lung and Thymus (LUNA): An Open-Label, Multicentre, Randomised, Phase 2 Trial","volume":"18","author":"Ferolla","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1200\/JCO.2010.33.7873","article-title":"Response, Survival, and Long-Term Toxicity after Therapy with the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers","volume":"29","author":"Imhof","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jtho.2020.01.009","article-title":"STING Pathway Expression Identifies NSCLC with an Immune-Responsive Phenotype","volume":"15","author":"Sen","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Andrini, E., Marchese, P.V., De Biase, D., Mosconi, C., Siepe, G., Panzuto, F., Ardizzoni, A., Campana, D., and Lamberti, G. (2022). Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051461"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/annonc\/mdv041","article-title":"Pulmonary Neuroendocrine (Carcinoid) Tumors: European Neuroendocrine Tumor Society Expert Consensus and Recommendations for Best Practice for Typical and Atypical Pulmonary Carcinoids","volume":"26","author":"Caplin","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00001622-200007000-00015","article-title":"Carcinoid and Pancreatic Endocrine Tumors: Recent Advances in Molecular Pathogenesis, Localization, and Treatment","volume":"12","author":"Jensen","year":"2000","journal-title":"Curr. Opin. Oncol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2141.1991.tb08125.x","article-title":"The Role of Interferons in the Management of Carcinoid Tumours","volume":"79","author":"Eriksson","year":"1991","journal-title":"Br. J. Haematol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1200\/JCO.2007.15.9020","article-title":"Activity of Sunitinib in Patients with Advanced Neuroendocrine Tumors","volume":"26","author":"Kulke","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/annonc\/mdw561","article-title":"Sunitinib in Pancreatic Neuroendocrine Tumors: Updated Progression-Free Survival and Final Overall Survival from a Phase III Randomized Study","volume":"28","author":"Faivre","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Deguelte, S., Perrier, M., Hammoutene, C., Cadiot, G., and Kianmanesh, R. (2020). Surgery and Perioperative Management in Small Intestinal Neuroendocrine Tumors. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072319"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40265-018-1033-0","article-title":"Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives","volume":"79","author":"Hofland","year":"2019","journal-title":"Drugs"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1477-2574.2010.00231.x","article-title":"T Cell Infiltrate and Outcome Following Resection of Intermediate-Grade Primary Neuroendocrine Tumours and Liver Metastases","volume":"12","author":"Katz","year":"2010","journal-title":"HPB"},{"key":"ref_206","first-page":"601","article-title":"Releasing the Brake on the Immune System: Ipilimumab in Melanoma and Other Tumors","volume":"25","author":"Tarhini","year":"2010","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/annonc\/mds213","article-title":"Ipilimumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Extensive-Disease-Small-Cell Lung Cancer: Results from a Randomized, Double-Blind, Multicenter Phase 2 Trial","volume":"24","author":"Reck","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4251\/wjgo.v12.i8.791","article-title":"Gastrointestinal Neuroendocrine Tumors in 2020","volume":"12","author":"Ahmed","year":"2020","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive Correlates of Response to the Anti-PD-L1 Antibody MPDL3280A in Cancer Patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/15\/5138\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:26:32Z","timestamp":1760127992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/15\/5138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,5]]},"references-count":209,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["jcm12155138"],"URL":"https:\/\/doi.org\/10.3390\/jcm12155138","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,5]]}}}